Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$136.82
+0.6%
$130.56
$110.86
$141.23
$236.77B0.695.20 million shs4.84 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$434.21
+1.9%
$343.03
$212.11
$488.54
$1.42T2.0686.28 million shs96.53 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.44%+4.12%+3.33%-0.95%+20.33%
Tesla, Inc. stock logo
TSLA
Tesla
+1.91%+5.89%+27.71%+27.53%+82.25%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$136.82
+0.6%
$130.56
$110.86
$141.23
$236.77B0.695.20 million shs4.84 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$434.21
+1.9%
$343.03
$212.11
$488.54
$1.42T2.0686.28 million shs96.53 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.44%+4.12%+3.33%-0.95%+20.33%
Tesla, Inc. stock logo
TSLA
Tesla
+1.91%+5.89%+27.71%+27.53%+82.25%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.90
Moderate Buy$145.226.14% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.33
Hold$324.53-25.26% Downside

Current Analyst Ratings Breakdown

Latest TSLA and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2025
Tesla, Inc. stock logo
TSLA
Tesla
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$400.00 ➝ $500.00
9/19/2025
Tesla, Inc. stock logo
TSLA
Tesla
Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
9/19/2025
Tesla, Inc. stock logo
TSLA
Tesla
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralOutperform$320.00 ➝ $548.00
9/18/2025
Tesla, Inc. stock logo
TSLA
Tesla
CICC Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$360.00 ➝ $450.00
9/18/2025
Tesla, Inc. stock logo
TSLA
Tesla
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$300.00 ➝ $395.00
9/17/2025
Tesla, Inc. stock logo
TSLA
Tesla
Dbs Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price Target$300.00 ➝ $450.00
9/15/2025
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$500.00
9/5/2025
Tesla, Inc. stock logo
TSLA
Tesla
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$410.00
9/5/2025
Tesla, Inc. stock logo
TSLA
Tesla
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$440.00
9/5/2025
Tesla, Inc. stock logo
TSLA
Tesla
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$147.00 ➝ $142.00
(Data available from 9/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.68$6.62 per share20.67$27.62 per share4.95
Tesla, Inc. stock logo
TSLA
Tesla
$97.69B14.78$3.95 per share110.00$22.89 per share18.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.9817.1523.882.5832.43%18.32%10.71%10/15/2025 (Estimated)
Tesla, Inc. stock logo
TSLA
Tesla
$7.13B$1.73250.99128.0914.866.54%7.98%4.79%10/22/2025 (Estimated)

Latest TSLA and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/15/2025Q3 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.30N/AN/AN/A$11.40 billionN/A
7/23/2025Q2 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.43$0.40-$0.03$0.33$23.18 billion$22.50 billion
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.26$1.26N/A$1.01$11.01 billion$11.14 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.72%N/A29.57%54 Years
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A

Latest TSLA and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/19/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.76%10/15/202510/15/202511/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.25
1.82
1.30
Tesla, Inc. stock logo
TSLA
Tesla
0.07
2.04
1.55

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Tesla, Inc. stock logo
TSLA
Tesla
19.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
125,6653.33 billion2.66 billionOptionable

Recent News About These Companies

Tesla (TSLA) Laps the Stock Market: Here's Why
Crypto Boom, Fed Cuts & Tesla’s Next Big Bet with Luke Lango
Top Insurance Stocks Worth Watching - September 22nd
Tesla (NASDAQ:TSLA) Trading 1.9% Higher on Analyst Upgrade
Tesla (TSLA) Stock Trades Up, Here Is Why
Utility Stocks Worth Watching - September 22nd
Best Solar Stocks To Consider - September 22nd
Promising Retail Stocks To Follow Today - September 22nd
Best Industrial Stocks To Follow Now - September 22nd

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$136.82 +0.78 (+0.57%)
Closing price 09/22/2025 03:59 PM Eastern
Extended Trading
$136.70 -0.13 (-0.09%)
As of 09/22/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Tesla stock logo

Tesla NASDAQ:TSLA

$434.21 +8.14 (+1.91%)
Closing price 09/22/2025 04:00 PM Eastern
Extended Trading
$436.38 +2.17 (+0.50%)
As of 09/22/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.